Explore Drugs Targeting RNA Riboswitches with Magna - Depixus
Depixus20 Mar, 2024Technology
Discover how Magna from Depixus aids in the exploration of drugs targeting RNA riboswitches. Uncover the latest advancements in drug discovery technology and revolutionize your approach to RNA-targeted therapies. Based on magnetic force spectroscopy, MAGNA is the first technology for exploring dynamic molecular interactions in real time from up to thousands of individual molecules. Here, we used it to probe the interactions between the PreQ1 riboswitch RNA from Bacillus subtilis (Bsu) and its natural ligand, PreQ1, or a synthetic ligand named Compound 4.
Related Bookmarks
- Enhance Customer Service with Shopify Helpdesk Apps
- Maritime Safety System Market Size, Share and Global Market Forecast to 2027
- Spectrum Internet Plans, Prices, and Packages
- Expert Developers for Travel Software Development Project
- Ready to supercharge your P21 business with the B2Sell Web API for Prophet 21?
- How is Python Useful for Cybersecurity in 2024
- WordPress Development Company in Chennai
- Boost Your Shopify Store with Account Invite Apps
- Best Insurance Broking Software Solution Company in India
- Revolutionizing Connectivity: The Kymeta Satellite Terminal and the Kymeta u8
Recent Profiles
915bet
Petersen Herndon
Trendora Shops
Melinda Prescott
Lykke Espersen
Noel Dalby
Munch Hawkins
Home Hygienist Llc
Hedrick Skov
Finley Ellison